Biotech Force Danmark ApS: Financial statements 2016
CVR: 36434309
Biotech Force Danmark ApS (CVR 36434309) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK 1,256,594 and a net result of DKK -378,154. Equity amounted to DKK 6,291,017. The solvency ratio was 14.6%.
- Gross Profit
- 1,256,594 kr.
- Profit/Loss
- -378,154 kr.
- Equity
- 6,291,017 kr.
- Total Assets
- 43,146,474 kr.
How creditworthy is Biotech Force Danmark ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2016
Biotech Force Danmark ApS has published its interim report for the period November 14, 2014 – December 31, 2015.
As of June 1, 2016, Joen-Magnus Reinert has joined the board of directors of Biotech Force Danmark ApS.
As of June 1, 2016, Nina Kjærgaard Reinert has joined the board of directors of Biotech Force Danmark ApS.
As of June 1, 2016, Anne Reinert Skovbakke has joined the board of directors of Biotech Force Danmark ApS.
As of June 1, 2016, Jette Kjærgaard has joined the board of directors of Biotech Force Danmark ApS.
As of June 1, 2016, Nina Kjærgaard Reinert is registered as adm. dir. of Biotech Force Danmark ApS.
As of June 1, 2016, Joen-Magnus Reinert has stepped down as director of Biotech Force Danmark ApS.
About Biotech Force Danmark ApS
Biotech Force Danmark ApS is a Danish company of the type Anpartsselskab based in Kolding, founded in 2014. The company is registered under the industry Engroshandel med rengøringsmidler. The company was previously named ANTi-COVID 19 Danmark ApS and GL. DONSVEJ 6 KOLDING ApS. The management consists of Jette Kjærgaard. The company's owners include JMR HOLDING, KOLDING A/S, PLAN Invest A/S and Reinert Family Invest ApS. In 2025, the company reported a gross profit of DKK -3,515,065 and a net result of DKK -4,321,793 compared with DKK -2,161,531 the year before. Equity amounted to DKK -18,527,805.
